Clinical Trial

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD

Name: A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD — clinical trial record (NCT07668518)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Study investigating the safety, tolerability, pharmacokinetics and early efficacy with KIT2014 over 7 days of treatment in moderate to severe chronic obstructive pulmonary disease patients.

Protocol Amendment History 1 change

critical Primary endpoint(s) modified 2026-07-10

Trial Details

NCT Number	NCT07668518
Lead Sponsor	Kither Biotech Srl Collaborators: Avance Clinical Pty Ltd.
Conditions	Chronic Obstructive Pulmonary Disease (COPD)
Enrollment	36 participants
Start Date	2026-07-01
Primary Completion	2027-03-31 (estimated)
Study Completion	2027-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-09